Dow Down 0.18% Nasdaq Up 0.39%

Biota Pharmaceuticals, Inc. (BOTA)

-NasdaqGS
2.33 Up 0.03(1.30%) 3:59PM EDT
Prev Close:2.30
Open:2.32
Bid:2.13 x 3000
Ask:3.00 x 4000
1y Target Est:3.00
Beta:0.81
Earnings Date:Sep 15 - Sep 19 (Est.)
Day's Range:2.30 - 2.35
52wk Range:2.29 - 7.07
Volume:11,613
Avg Vol (3m):116,780
Market Cap:81.77M
P/E (ttm):N/A
EPS (ttm):-0.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for BOTA

Comparison

Symbol% ChgMkt Cap
BOTAUp 1.30%81.77M
BCRXDown 4.74%922.78M
EBSDown 0.64%927.18M
RHHBYUp 0.14%248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1.16
Ex-Dividend Date:09-Nov-12

Analysts

Annual EPS Est (Jun-14) :-0.22
Quarterly EPS Est (Jun-14) :-0.18
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biota Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of anti-infective products in Australia. The company is developing oral, small molecule compounds to treat various viral and bacterial infections. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback